Latest News & Blogs from The Foundation

January 31, 2023

CurePSP extends its partnership with the Rainwater Charitable Foundation to accelerate the development of neuroimaging human biomarkers for progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and other primary tauopathies

NEW YORK, Jan. 31, 2023 /PRNewswire/ — CurePSP has awarded a $90,000 grant for the pre-clinical and clinical development of a high-affinity...

News

January 20, 2023

CurePSP launches a new annual grant program to promote collaboration and advance clinical care research

NEW YORK, Jan. 20, 2023 /PRNewswire/ — CurePSP has announced the recipients of the first Collaborative Approaches to Resources, Educati...

News

November 17, 2022

CurePSP Expands Specialized Care Network for Rare Neurodegenerative Diseases

NEW YORK (November 17, 2022) /PRNewswire/ — CurePSP has announced the designation of Queen’s Parkinson’s and Movement Disorders Center in Hawaii...

News

November 02, 2022

CurePSP is hiring! Join us in our mission!

Professional OpportunityDirector / Associate Director of Scientific Affairs and PartnershipsDOWNLOAD JOB DESCRIPTION HEREThe Opportunity:CurePSP seeks...

News

November 02, 2022

Judy Coughlin, Wife of Former NFL Coach Tom Coughlin, Dies at 77

Judy Coughlin, the wife of ex-NFL head coach and executive Tom Coughlin, died Wednesday at the age of 77 after a lengthy battle with progressive supra...

News

September 30, 2022

Lecanemab for Alzheimer’s: “Proof of Principle” for PSP, CBD and MSA

By Lawrence I. Golbe, MD, Chief Clinical Officer and Scientific Advisory Board Chair, CurePSPGreat news for people with Alzheimer’s disease: A monoclo...

News

September 27, 2022

Doing it for John: Bonelli Music Bash Returns for a Seventh Straight Year

 Lois Bonelli never has to worry if enough people will attend her event. As she prepares for the 7th Annual Bonelli Music Bash to honor her late...

News

September 22, 2022

CurePSP Joins the Unified Parkinson’s Advocacy Council

CurePSP is excited to announce that we have joined the Unified Parkinson’s Advocacy Council (UPAC)! UPAC was created by the Michael J. Fox F...

News

September 19, 2022

The Ream Family Marches Past Their Goals

When Mary Kay Ream was diagnosed with progressive supranuclear palsy (PSP) in the fall of 2019 her family — husband Roger and daughters Alanna, Kelly,...

News

August 23, 2022

CurePSP Summer Newsletter Out Now

The latest CurePSP Connection newsletter gives an update from Dr. Kristophe Diaz on the allocation of your funds, a Q&A with Centers of Care...

News

August 10, 2022

For Carepartners, No Moment is More Important Than the Present

When Rafi Stern was a kid, the grass oval in the middle of the Stuyvesant Town apartment village was strictly off-limits. He and his mother, Suzanne W...

News

August 03, 2022

Through the generosity of the Light of Day Foundation, CurePSP has received a matching grant of $50,000!

Every dollar you give towards the Hope Tour will be doubled!DONATE NOWFor more than a decade, CurePSP and the Light of Day Foundation have partnered i...

News

July 22, 2022

Dr. John Steele, Fondly Remembered

By Lawrence I. Golbe, MD Chief Clinical Officer, CurePSPThe PSP community mourns the passing of neurologist John C. Steele, MD on May 21, 2022, surrou...

News

July 18, 2022

Andy Maus Assumes Board Chair Ready for Progress

Andy Maus knows that great systems aren’t built overnight. As the head of the Compass One Healthcare human resources department he oversees human reso...

News

June 29, 2022

Diane Deaver Keeps it Moving Through her Quilts and Poetry

After being released from an emergency room in Alaska, Diane Deaver needed to pick up her Bell’s Palsy medication. She asked her son-in-law to make on...

News

June 13, 2022

The AMULET study: A clinical research study for people living with MSA

To MSA patients and carepartners: at CurePSP, we work hard to follow developments by the pharmaceutical companies around the world that are advancing...

News

May 25, 2022

CurePSP Elects Senior Healthcare Executive as Its Board Chair

Andy Maus will apply his personal and professional experience to advancing the foundation’s mission.NEW YORK, May 25, 2022  — CurePSP, the leadin...

News

May 21, 2022

CurePSP Centers of Care Lean on Each Other to Improve Care of PSP, CBD and MSA

When Dr. Miriam Sklerov first had the idea for a CurePSP Center of Care at the University of North Carolina Medical Center, she didn’t know where to s...

News

April 26, 2022

Ken’s Resilience: A Shared Ride for Hope and Support

When the snow finally melts in St. Alban’s, Vermont, it would take everything to stop Ken Appel from completing his 20-mile bike ride along the Missis...

News

April 18, 2022

Checking in on Previously Funded Venture Grants: Where Are They Now?

CurePSP has always believed in the collaborative nature of research. By combining the work of scientists who have produced compelling research in...

News

April 05, 2022

Marty Rimestad Finds New Ways to Explore the Outdoors

If Marty and Wanda Rimestad could be anywhere, they would probably be perched in the breakfast nook of their old home in the countryside of Amery, Wis...

News

March 21, 2022

Dr. Sally Temple Looks Ahead

Dr. Sally Temple doesn’t have time to feel pressure. For over three decades she has responded to uncertainty with the same remedy: more research. But...

News

March 15, 2022

Marco Island Takes its Biggest Step Towards a Cure Yet

Cindy MacDonald lets out a virtual gasp when I tell her that over 100 people had already registered for the 19th Annual CurePSP Awareness and Memorial...

News

October 21, 2021

CurePSP appoints former UNC Movement Disorders Center coordinator to its top programs position

Jessica Shurer, MSW, LCSWJessica Shurer will head the foundation’s patient and family support and help expand its Centers of Care.NEW YORK, Oct....

News

September 14, 2021

CurePSP funds four new grants to advance treatment of prime of life neurodegeneration

 Studies at leading institutions may result in therapeutic approaches for PSP, CBD, FTD, and related diseases.NEW YORK, Sept. 10, 2021 ...

News

August 09, 2021

CurePSP appoints Dr. Kristophe Diaz as the foundation’s chief executive

Kristophe Diaz, PhDA scientist with broad experience in life sciences will lead the organization’s research, programs, and fundraising initiatives.NEW...

News

July 06, 2021

CurePSP’s clinical guide to rare neurodegenerative conditions is published by leading neurology journal

Frontiers in Neurology today published a consensus statement on the best practices in the clinical management of progressive supranuclear palsy (...

News

June 16, 2021

FAQ on FDA Approval of Aducanumab

 On June 7, 2021, the FDA approved aducanumab, a monoclonal antibody made by Biogen, for use in Alzheimer’s disease in the US.  Here’s...

News

June 03, 2021

VA plans expansion of benefits for disability claims for conditions related to certain toxic exposures

 New evaluation process to be applied in identifying future presumptive conditionVA announced today two major decisions related to presumptive co...

News

April 20, 2021

CurePSP awards three new Venture Grants for the study of PSP and CBD

Studies will focus on toxic protein in the brain and genetic factorsCurePSP has awarded Venture Grants to three researchers studying tau protein patho...

News

February 15, 2021

CurePSP and the Rainwater Charitable Foundation partner to support a collaborative biobanking platform for frontotemporal dementia research

Partnership will support efforts to enhance quantity and quality of neuropathologic FTD research worldwideThe Rainwater Charitable Foundation&nbs...

News

December 18, 2020

UCB pauses the development of bepranemab for progressive supranuclear palsy

A note from Kristophe Diaz, PhD, CurePSP Vice President- Scientific AffairsTo our patients, caregivers, supporters, advocates, and volunteers:At CureP...

News

December 15, 2020

Advisory on COVID-19 vaccines and PSP, CBD, and MSA from Lawrence I. Golbe, MD

Advisory on COVID-19 VaccinesFrom Lawrence I. Golbe, MD, Director of Clinical Affairs, CurePSPI am clinical director at CurePSP, a nonprofit based in...

News

August 11, 2020

CurePSP Partners With Rainwater to Support Pioneering Neurodegeneration Research

Study will use ‘miniature brains’ cultivated from stem cells to study protein mutationsTweet thisNEW YORK–(BUSINESS WIRE)–CurePSP has awarded a $100,0...

News

August 10, 2020

Promotus Launched as Global Alliance of PSP and CBD NGO’s

Will be key resource for patient advocacy, research, and clinical trialsTweet thisNEW YORK — Promotus (www.promotus.org) has been launched as a g...

News

June 03, 2020

CurePSP Cancels In-Person Events

From Bill McFarland, Chair, Board of DirectorsOn behalf of the CurePSP, Inc., Board of Directors, I’m writing to let you know that given the...

News

April 14, 2020

Scientific American Article Cites Tau Protein as Linchpin to Finding Neurodegeneration Cure

In a recently published article, “Tau Shows Promise as Achilles’ Heel for Alzheimer’s and Similar Diseases,” the respected journal Scientifi...

News

March 27, 2020

Update Regarding COVID-19 Virus

We at CurePSP recognize that many of you coping with the struggles and challenges that PSP and other neurodegenerative diseases present may be facing...

News

March 10, 2020

CurePSP’s approach during the coronavirus outbreak

To the CurePSP CommunityCurePSP’s approach during the coronavirus outbreakCurePSP’s primary concern during the coronavirus outbreak is the welfare of...

News

March 10, 2020

Advisory on Coronavirus From Lawrence I. Golbe, MD

Advisory on PSP and the CoronavirusFrom Lawrence I. Golbe, MD, Director of Clinical AffairsThose with PSP are at special risk with regard to the coron...

News

December 19, 2019

Biogen Ends Trial of Its Drug for PSP

Our Letter to the PSP Community Regarding Biogen Trial ResultsBy Lawrence I. Golbe, MD, Director of Scientific AffairsThe pharmaceutical company Bioge...

News

September 13, 2019

CurePSP Image Library

Every year we are continuously growing our number of volunteers who are helping spread awareness and hosting fundraisers to support our vital programs...

News

July 29, 2019

AbbVie Ends Tau Antibody Study

AbbVie has ended the clinical trial of its intravenously administered antibody designed to slow the progression of PSP when it failed to show benefit....

News

July 29, 2019

CurePSP Awards Seven New Research Grants

NEW YORK–(July 29, 2019)–CurePSP, the foundation for prime of life neurodegeneration, has awarded grants to scientific research into progressive supra...

News

April 11, 2019

The Mystery of My Brother’s Brain – a personal story

Laurence S. BraudeThis story comes to us from Solna Braude, who shares her brother’s journey in finding a definitive diagnosis for his neurological di...

News

March 28, 2019

CurePSP Names Dr. Lawrence I. Golbe, Eminent Clinician, as Head of Scientific Affairs

He succeeds Dr. Alex Klein, who moves to UCB post in BrusselsDr. Lawrence I. GolbeNEW YORK (February 20, 2019) – CurePSP, the foundation for prime of...

News

October 18, 2018

Mama’s Legacy

This story comes to us from Noha Al-Awadi about her mother and her battle with progressive supranuclear palsy. Tuesday, October 9th, 2018 ma...

News

October 17, 2018

Rush University Medical Center Caregiver Study

Have You Been a Caregiver for Someone with Parkinson’s Disease, PSP, MSA, CBD, or a related disorder?You have learned a lot by caring for your loved o...

News

October 11, 2018

In Conversation with John Burhoe, Sr.

On Friday, October 5, CurePSP Board Director Amy Branch sat down with John Burhoe Sr., CurePSP Chair Emeritus, to discuss his thoughts on the progress...

News

September 27, 2018

FREE Webinar, October 18

Caregivers’ Search for MeaningFor family and professional caregiversby Janet Edmunson, M.Ed.WHEN: Thursday, October 18, 2018 (The webinar also wi...

News